U.S. flag

An official website of the United States government

NM_000517.6(HBA2):c.89T>C (p.Leu30Pro) AND HEMOGLOBIN AGRINIO

Germline classification:
other (1 submission)
Last evaluated:
Sep 12, 2022
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000016937.2

Allele description [Variation Report for NM_000517.6(HBA2):c.89T>C (p.Leu30Pro)]

NM_000517.6(HBA2):c.89T>C (p.Leu30Pro)

Genes:
LOC106804612:hemoglobin subunit alpha 2 recombination region [Gene]
HBA2:hemoglobin subunit alpha 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_000517.6(HBA2):c.89T>C (p.Leu30Pro)
Other names:
L29P
HGVS:
  • NC_000016.10:g.173001T>C
  • NG_000006.1:g.33864T>C
  • NG_046165.1:g.2740T>C
  • NG_059186.1:g.1351T>C
  • NG_059271.1:g.5155T>C
  • NM_000517.6:c.89T>CMANE SELECT
  • NP_000508.1:p.Leu30Pro
  • LRG_1240t1:c.89T>C
  • LRG_1225:g.1351T>C
  • LRG_1240:g.5155T>C
  • LRG_1240p1:p.Leu30Pro
  • NC_000016.9:g.223000T>C
  • NM_000517.4:c.89T>C
Protein change:
L30P; LEU29PRO
Links:
OMIM: 141850.0026; dbSNP: rs41341344
NCBI 1000 Genomes Browser:
rs41341344
Molecular consequence:
  • NM_000517.6:c.89T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
HEMOGLOBIN AGRINIO
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037208OMIM
no assertion criteria provided
other
(Sep 12, 2022)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A base substitution (T-->C) in codon 29 of the alpha 2-globin gene causes alpha thalassaemia.

Hall GW, Thein SL, Newland AC, Chisholm M, Traeger-Synodinos J, Kanavakis E, Kattamis C, Higgs DR.

Br J Haematol. 1993 Nov;85(3):546-52.

PubMed [citation]
PMID:
8136277

An alpha-thalassemic hemoglobinopathy: homozygosity for the HB Agrinio alpha 2-globin chain variant.

Traeger-Synodinos J, Metaxotou-Mavromati A, Kanavakis E, Vrettou C, Papassotiriou I, Michael T, Kattamis C.

Hemoglobin. 1998 May;22(3):209-15.

PubMed [citation]
PMID:
9629496

Details of each submission

From OMIM, SCV000037208.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Hb Agrinio was discovered by Hall et al. (1993) in 3 individuals of Greek origin with an atypical form of Hb H disease (613978) characterized by a severe hypochromic, microcytic anemia. Hall et al. (1993) indicated that the mutation consisted of a T-to-C transition in codon 29 of the HBA2 gene causing a leucine-to-proline transition. Although each affected individual was a compound heterozygote for Hb Agrinio and a previously described mutation affecting the poly(A) addition signal of the HBB gene (141900.0383), simple heterozygotes for the leu29-to-pro mutation have the phenotype of the alpha-thalassemia trait.

Traeger-Synodinos et al. (1998) reported the first case of homozygosity for Hb Agrinio. The leu29-to-pro amino acid substitution in alpha-2-globin was caused by a CTG-to-CCG transition. The 12-month-old Greek proband presented with marked hypochromic microcytic anemia, a very low level of Hb H, rare Hb H inclusions, and a balanced alpha/non-alpha biosynthesis ratio. At the age of 13 years, the proband had a clinical phenotype compatible with mild thalassemia intermedia with moderate anemia (Hb = 7-8 g/dL), normal growth and development, slight splenomegaly, and minimal bone changes, while Hb H and inclusion bodies were not detected.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024